|
Revenue from operations jumped 27.17% to Rs 295.45 crore during the quarter as compared with Rs 232.33 crore posted in corresponding quarter last year.
Profit before tax stood at Rs 71.39 crore, increase 161.6% YoY during the quarter.
Total expenses jumped 11.01% to Rs 232.17 crore in Q1 FY24 as compared with Rs 209.14 crore in Q1 FY23. Cost of material consumed was at Rs 19.07 crore ( up 20.01% YoY), employee benefit expenses stood at Rs 54.97 crore ( down 19.6% YoY), selling marketing & distribution expenses was at Rs 21.26 crore(up 98.14% YoY).
Astrazeneca Pharma India is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and also provides clinical trial services to an overseas group company.
The scrip hit 52 week high at Rs 4,254.65 in intraday today.
|